Centiva Capital, LP Relay Therapeutics, Inc. Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$7.5 - $12.07 $95,062 - $152,987
12,675 New
12,675 $105,000
Q2 2021

Aug 16, 2021
SELL
$27.5 - $38.19 $511,307 - $710,066
-18,593 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$32.52 - $61.53 $604,644 - $1.14 Million
18,593 New
18,593 $643,000

Others Institutions Holding RLAY

# of Institutions
204
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $537M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email